Cafeteria diet inhibits insulin clearance by reduced insulindegrading enzyme expression and mRNA splicing

Journal of Endocrinology

Volumn 219, Issue 2, 2013, Pages 173-182

  Brandimarti, P ^a   Costa Junior J M ^a   Ferreira, S M ^a   Protzek, A O ^a   Santos, G J ^a   Carneiro, E M ^a   Boschero, A C ^a   Rezende, L F ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

Cafeteria diet; Diabetes; Insulin clearance; Insulin degrading enzyme; Obesity

Indexed keywords

GLUCOSE; INSULIN; INSULINASE; MESSENGER RNA;

ALTERNATIVE RNA SPLICING; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CAFETERIA DIET; CONTROLLED STUDY; DIET; EX VIVO STUDY; FEMALE; GASTROCNEMIUS MUSCLE; GLUCOSE HOMEOSTASIS; GLUCOSE TOLERANCE TEST; HYPOTHALAMUS; INSULIN BLOOD LEVEL; INSULIN CLEARANCE; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN SENSITIVITY; INSULIN TOLERANCE TEST; INTRAABDOMINAL FAT; LIVER; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PANCREAS ISLET; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKELETAL MUSCLE; WESTERN BLOTTING;

CAFETERIA DIET; DIABETES; INSULIN CLEARANCE; INSULIN-DEGRADING ENZYME; OBESITY;

ANIMALS; DIETARY CARBOHYDRATES; DIETARY FATS; DISEASE MODELS, ANIMAL; EATING; FEMALE; INSULIN; INSULIN RESISTANCE; INSULYSIN; LIVER; MICE; MUSCLE, SKELETAL; OBESITY; RNA SPLICING; RNA, MESSENGER;

EID: 84885714792     PISSN: 00220795     EISSN: 14796805     Source Type: Journal    
DOI: 10.1530/JOE-13-0177     Document Type: Article

References (47)

1. Ahrén B, Thomaseth K & Pacini G 2005 Reduced insulin clearance contributes to the increased insulin levels after administration of glucagon-like peptide 1 in mice. Diabetologia 48 2140-2146. (doi:10.1007/s00125-005-1915-z)
2. Amata O, Marino T, Russo N & Toscano M 2009 Human insulin-degrading enzyme working mechanism. Journal of the American Chemical Society 131 14804-14811. (doi:10.1021/ja9037142)
3. Balent B, Goswami G, Goodloe G, Rogatsky E, Rauta O, Nezami R, Mints L, Angeletti RH & Stein DT 2002 Acute elevation of NEFA causes hyperinsulinemia without effect on insulin secretion rate in healthy human subjects. Annals of theNew York Academy of Sciences 967 535-543. (doi:10.1111/j.1749-6632.2002.tb04313.x)
4. ButterfieldWJ 1970 Insulin clearance in nondiabetic and diabetic subjects. Panminerva Medica 12 233-235.
5. Castell-Auví A, Cedó L, Pallare's V, Blay M, Ardévol A & Pinent M 2012 The effects of a cafeteria diet on insulin production and clearance in rats. British Journal of Nutrition 108 1155-1162. (doi:10.1017/ S0007114511006623)
6. Chandra J, Zhivotovsky B, Zaitsev S, Juntti-Berggren L, Berggren PO & Orrenius S 2001 Role of apoptosis in pancreatic b-cell death in diabetes. Diabetes 50(Suppl 1) S44-S47. (doi:10.2337/diabetes.50.2007.S44)
7. Duckworth WC 1988 Insulin degradation: mechanisms, products, and significance. Endocrine Reviews 9 319-345. (doi:10.1210/edrv-9-3-319)
8. Duckworth WC, Bennett RG & Hamel FG 1998 Insulin degradation: progress and potential. Endocrine Reviews 19 608-624. (doi:10.1210/ er.19.5.608)
9. Erdmann J, Kallabis B, Oppel U, Sypchenko O, Wagenpfeil S & Schusdziarra V 2008 Development of hyperinsulinemia and insulin resistance during the early stage of weight gain. American Journal of Physiology. Endocrinology and Metabolism 294 E568-E575. (doi:10.1152/ ajpendo.00560.2007)
10. Erdmann J, Mayr M, Oppel U, Sypchenko O, Wagenpfeil S & Schusdziarra V 2009 Weight-dependent differential contribution of insulin secretion and clearance to hyperinsulinemia of obesity. Regulatory Peptides 152 1-7. (doi:10.1016/j.regpep.2008.10.008)
11. Farris W, Leissring MA, Hemming ML, Chang AY & Selkoe DJ 2005 Alternative splicing of human insulin-degrading enzyme yields a novel isoform with a decreased ability to degrade insulin and amyloid b-protein. Biochemistry 44 6513-6525. (doi:10.1021/bi0476578)
12. Fernández-Gamba A, Leal MC, Morelli L & Castaño EM 2009 Insulin-degrading enzyme: structure-function relationship and its possible roles in health and disease. Current Pharmaceutical Design 15 3644-3655. (doi:10.2174/138161209789271799)
13. Goodarzi MO, Cui J, Chen YD, Hsueh WA, Guo X & Rotter JI 2011 Fasting insulin reflects heterogeneous physiological processes: role of insulin clearance. American Journal of Physiology. Endocrinology and Metabolism 301 E402-E408. (doi:10.1152/ajpendo.00013.2011)
14. Groves CJ, Wiltshire S, Smedley D, Owen KR, Frayling TM, Walker M, Hitman GA, Levy JC, O'Rahilly S, Menzel S et al. 2003 Association and haplotype analysis of the insulin-degrading enzyme (IDE) gene, a strong positional and biological candidate for type 2 diabetes susceptibility. Diabetes 52 1300-1305. (doi:10.2337/diabetes. 52.5.1300)
15. Guo X, Cui J, Jones MR, Haritunians T, Xiang AH, Chen YD, Taylor KD, Buchanan TA, Davis RC, Hsueh WA et al. 2012 Insulin clearance: confirmation as a highly heritable trait, and genome-wide linkage analysis. Diabetologia 55 2183-2192. (doi:10.1007/s00125-012-2577-2)
16. Hamel FG, Upward JL & Bennett RG 2003 In vitro inhibition of insulindegrading enzyme by long-chain fatty acids and their coenzyme A thioesters. Endocrinology 144 2404-2408. (doi:10.1210/en.2002-0007)
17. Karamohamed S, Demissie S, Volcjak J, Liu C, Heard-Costa N, Liu J, Shoemaker CM, Panhuysen CI, Meigs JB, Wilson P et al. 2003 Polymorphisms in the insulin-degrading enzyme gene are associated with type 2 diabetes in men from the NHLBI Framingham Heart Study. Diabetes 52 1562-1567. (doi:10.2337/diabetes.52.6.1562)
18. Kim M, Hersh LB, Leissring MA, Ingelsson M, Matsui T, Farris W, Lu A, Hyman BT, Selkoe DJ, Bertram L et al. 2007 Decreased catalytic activity of the insulin-degrading enzyme in chromosome 10-linked Alzheimer disease families. Journal of Biological Chemistry 282 7825-7832. (doi:10.1074/jbc.M609168200)
19. Kotronen A, Vehkavaara S, Seppälä-Lindroos A, Bergholm R & Yki-Järvinen H 2007 Effect of liver fat on insulin clearance. American Journal of Physiology. Endocrinology and Metabolism 293 E1709-E1715. (doi:10.1152/ajpendo.00444.2007)
20. Kotronen A, Juurinen L, Tiikkainen M, Vehkavaara S & Yki-Järvinen H 2008 Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes. Gastroenterology 135 122-130. (doi:10.1053/j.gastro.2008.03.021)
21. Kuo WL, Gehm BD & Rosner MR 1991 Regulation of insulin degradation: expression of an evolutionarily conserved insulin-degrading enzyme increases degradation via an intracellular pathway. Molecular Endocrinology 5 1467-1476. (doi:10.1210/mend-5-10-1467)
22. Kwak SH, Cho YM, Moon MK, Kim JH, Park BL, Cheong HS, Shin HD, Jang HC, Kim SY, Lee HK et al. 2008 Association of polymorphisms in the insulin-degrading enzyme gene with type 2 diabetes in the Korean population. Diabetes Research and Clinical Practice 79 284-290. (doi:10.1016/j.diabres.2007.08.017)
23. Leissring MA, Malito E, Hedouin S, Reinstatler L, Sahara T, Abdul-Hay SO, Choudhry S, Maharvi GM, Fauq AH, Huzarska M et al. 2010 Designed inhibitors of insulin-degrading enzyme regulate the catabolism and activity of insulin. PLoS ONE 5 e10504. (doi:10.1371/journal.pone. 0010504)
24. Li CZ, Zhang SH, Shu CD & Ren W 2002 Relationship between insulindegrading enzyme activity and insulin sensitivity in cell model of insulin-resistance. Di Yi Jun Yi Da Xue Xue Bao 22 151-154.
25. Matveyenko AV, Veldhuis JD & Butler PC 2008 Adaptations in pulsatile insulin secretion, hepatic insulin clearance, and b-cell mass to age-related insulin resistance in rats. American Journal of Physiology. Endocrinology and Metabolism 295 E832-E841. (doi:10.1152/ajpendo. 90451.2008)
26. McCarroll AM & Buchanan KD 1973 Insulin clearance by the isolated perfused livers of insulin deficient rats. Diabetologia 9 457-460. (doi:10.1007/BF00461688)
27. Mckeigue PM, Uusitupa M, Laitinen J, Mäkinen E & Schwab U 1991 Insulin clearance and diabetes. Lancet 338 1270-1271. (doi:10.1016/ 0140-6736(91)92135-O)
28. Mittelman SD, Van Citters GW, Kim SP, Davis DA, Dea MK, Hamilton-Wessler M & Bergman RN 2000 Longitudinal compensation for fat-induced insulin resistance includes reduced insulin clearance and enhanced b-cell response. Diabetes 49 2116-2125. (doi:10.2337/diabetes.49.12.2116)
29. Nijs HG, Radder JK, Frölich M & Krans HM 1990 In vivo relationship between insulin clearance and action in healthy subjects and IDDM patients. Diabetes 39 333-339. (doi:10.2337/diabetes.39.3.333)
30. Pivovarova O, Gögebakan O, Pfeiffer AF & Rudovich N 2009 Glucose inhibits the insulin-induced activation of the insulin-degrading enzyme in HepG2 cells. Diabetologia 52 1656-1664. (doi:10.1007/ s00125-009-1350-7)
31. Porte D, Baskin DG & Schwartz MW 2005 Insulin signaling in the central nervous system: a critical role in metabolic homeostasis and disease from C. elegans to humans. Diabetes 54 1264-1276. (doi:10.2337/ diabetes.54.5.1264)
32. Prada PO, Zecchin HG, Gasparetti AL, Torsoni MA, Ueno M, Hirata AE, Corezola do Amaral ME, Höer NF, Boschero AC & Saad MJ 2005 Western diet modulates insulin signaling, c-Jun N-terminal kinase activity, and insulin receptor substrate-1ser307 phosphorylation in a tissue-specific fashion. Endocrinology 146 1576-1587. (doi:10.1210/ en.2004-0767)
33. Rabkin R, Reaven GM & Mondon CE 1986 Insulin metabolism by liver, muscle, and kidneys from spontaneously diabetic rats. American Journal of Physiology 250 E530-E537.
34. Rezende LF, Stoppiglia LF, Souza KL, Negro A, Langone F & Boschero AC 2007 Ciliary neurotrophic factor promotes survival of neonatal rat islets via the BCL-2 anti-apoptotic pathway. Journal of Endocrinology 195 157-165. (doi:10.1677/JOE-07-0016)
35. Rezende LF, Vieira AS, Negro A, Langone F & Boschero AC 2009 Ciliary neurotrophic factor (CNTF) signals through STAT3-SOCS3 pathway and protects rat pancreatic islets from cytokine-induced apoptosis. Cytokine 46 65-71. (doi:10.1016/j.cyto.2008.12.014)
36. Rezende LF, Santos GJ, Santos-Silva JC, Carneiro EM & Boschero AC 2012 Ciliary neurotrophic factor (CNTF) protects non-obese Swiss mice against type 2 diabetes by increasing b cell mass and reducing insulin clearance. Diabetologia 55 1495-1504. (doi:10.1007/ s00125-012-2493-5)
37. Rothwell NJ & Stock MJ 1979 Regulation of energy balance in two models of reversible obesity in the rat. Journal of Comparative and Physiological Psychology 93 1024-1034. (doi:10.1037/h0077631)
38. Rudovich N, Pivovarova O, Fisher E, Fischer-Rosinsky A, Spranger J, Möhlig M, Schulze MB, Boeing H & Pfeiffer AF 2009 Polymorphisms within insulin-degrading enzyme (IDE) gene determine insulin metabolism and risk of type 2 diabetes. Journal of Molecular Medicine 87 1145-1151. (doi:10.1007/s00109-009-0540-6)
39. Sampey BP, Vanhoose AM, Winfield HM, Freemerman AJ, Muehlbauer MJ, Fueger PT, Newgard CB & Makowski L 2011 Cafeteria diet is a robust model of human metabolic syndrome with liver and adipose inflammation: comparison to high-fat diet. Obesity 19 1109-1117. (doi:10.1038/oby.2011.18)
40. Santos GJ, Oliveira CA, Boschero AC & Rezende LF 2011 CNTF protects MIN6 cells against apoptosis induced by Alloxan and IL-1b through downregulation of theAMPK pathway. Cellular Signalling 23 1669-1676. (doi:10.1016/j.cellsig.2011.06.001)
41. Sclafani A & Springer D 1976 Dietary obesity in adult rats: similarities to hypothalamic and human obesity syndromes. Physiology & Behavior 17 461-471. (doi:10.1016/0031-9384(76)90109-8)
42. Slominskiǐ PA, Pivovarova OV, Shadrina MI, Artem'eva AV, Pfaipffer FG, Rudovich NN, Agadzhanian SE, Pronin VS & Limborskaia SA 2009 Association of insulinase gene polymorphisms with type 2 diabetes mellitus in patients from the Moscow population. Genetika 45 127-131.
43. Strömblad G & Björntorp P 1986 Reduced hepatic insulin clearance in rats with dietary-induced obesity. Metabolism 35 323-327. (doi:10.1016/ 0026-0495(86)90148-4)
44. Valera Mora ME, Scarfone A, Calvani M, Greco AV & Mingrone G 2003 Insulin clearance in obesity. Journal of the American College of Nutrition 22 487-493. (doi:10.1080/07315724.2003.10719326)
45. Vanzela EC, Ribeiro RA, de Oliveira CA, Rodrigues FB, Bonfleur ML, Carneiro EM, Souza KL & Boschero AC 2010 Pregnancy restores insulin secretion from pancreatic islets in cafeteria diet-induced obese rats. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology 298 R320-R328. (doi:10.1152/ajpregu.00256.2009)
46. Wiesenthal SR, Sandhu H, McCall RH, Tchipashvili V, YoshiiH, Polonsky K, Shi ZQ, Lewis GF, Mari A& Giacca A 1999 Free fatty acids impair hepatic insulin extraction in vivo. Diabetes 48 766-774. (doi:10.2337/diabetes. 48.4.766)
47. YoshiiH, LamTK, GuptaN, Goh T, Haber CA, Uchino H, Kim TT, Chong VZ, Shah K, Fantus IG et al. 2006 Effects of portal free fatty acid elevation on insulin clearance andhepatic glucose flux. American Journal of Physiology. Endocrinology and Metabolism 290 E1089-E1097. (doi:10.1152/ajpendo. 00306.2005)